WE ARE

TheAI first genomicscompany.

We are starting with the first personalised mRNA cancer vaccines for dogs, built from each dog's own tumour.

N of 1 medicine is the future.

We can read biology like never before. We can sequence a tumour and see the exact mutations driving it. So why do dogs with cancer still get the same few options?

Same diagnosis. Different biology. The treatment should know the difference. That means moving from treatments designed for populations to a treatment designed for one patient.

The idea is not new. Doing it at scale is. AI is what changed that: one pipeline reads the tumour, finds the mutations that matter, and designs the vaccine to match.

A dog receiving care
Where we're starting

Why dogs first.

We started with dog cancer because of Rosie. But it is also one of the hardest problems in medicine to solve.

Dogs get the same cancers we get, arising on their own inside working immune systems. Their disease moves fast, so the science answers in years instead of decades. And they are handed the bluntest treatments in medicine.

Read the full report →
1 in 4
will face cancer in their lifetime
1 in 2
once they pass the age of ten

Veterinary Cancer Society, cited by the American Veterinary Medical Association.

Who we’re building this for

Who we're building this for
A dog outdoors
Our horizon

Dog cancer is the beginning.

We are not only proving that a personalised vaccine works. We are using AI to build autonomous systems that read biological failure, discover how to control it, and design precise repairs.

Get that right and cancer stops looking like one disease. It starts looking like one instance of a much larger problem.

Apply now →

Gamgee is pioneering N of 1 treatment
for
in every